Biodistribution of 89Zirconium-labelled GSK2398852 Using PET Imaging

NCT03417830 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Stopped Change in benefit/risk profile.

Conditions

Amyloidosis

Interventions

DRUG: GSK2315698 (CPHPC)
DRUG: GSK2398852 (unlabeled anti-SAP mAb)
DRUG: 89Zr-GSK2398852 (89Zr-labeled anti-SAP mAb)

Sponsor

GlaxoSmithKline